Gonasi Hp (Chorionic Gonadotrophin)

Gonasi Hp is indicated for several reproductive and endocrine indications under medical supervision.

• Induction of ovulation in women with anovulatory infertility.
• Support of the luteal phase during assisted reproductive technology cycles.
• Treatment of infertility associated with luteinizing hormone deficiency.
• Management of cryptorchidism in male infants.
• Adjunct therapy for certain cases of hypogonadism.
• Facilitation of sperm production in men with hypogonadotropic hypogonadism.

Adverse reactions to Gonasi Hp may vary in frequency and severity.

Common

• Injection site pain, redness, or swelling.
• Headache.
• Nausea or mild gastrointestinal discomfort.
• Fatigue or mild dizziness.
• Mood changes such as irritability.
• Mild flu-like symptoms.

Serious

• Ovarian hyperstimulation syndrome (OHSS).
• Allergic reactions including rash, itching, or anaphylaxis.
• Thromboembolic events.
• Rapid weight gain due to fluid retention.
• Severe abdominal pain.
• Severe hypertension.
• Life‑threatening anaphylactic reaction.

Before prescribing Gonasi Hp, clinicians should consider several precautionary factors to ensure safe use.

• Assess for contraindications such as active ovarian cysts or uncontrolled thyroid disease.
• Evaluate the patient’s risk for ovarian hyperstimulation syndrome, especially in assisted reproduction.
• Review history of allergic reactions to hCG or any component of the formulation.
• Monitor for signs of thromboembolic disorders in patients with clotting risk factors.
• Use caution in patients with cardiovascular disease or hypertension.
• Adjust dosing in pediatric patients treated for cryptorchidism under specialist guidance.
• Avoid use during pregnancy unless specifically indicated for luteal support.

Gonasi Hp may interact with other medications or substances that affect hormonal balance or coagulation.

Avoid

• Concurrent use of estrogen‑containing contraceptives, which may reduce hCG efficacy.
• Medications that increase the risk of thrombosis, such as hormonal therapy or certain chemotherapy agents.
• High‑dose corticosteroids, which may mask allergic reactions.

Use with caution

• Anticoagulants, as hCG can influence clotting factors.
• Thyroid hormone replacement, because hCG can affect thyroid function tests.
• Other gonadotropins, requiring careful dose adjustment and monitoring.
• GnRH analogues, as combined therapy may alter ovulation response.
• Other hormonal agents, necessitating close clinical supervision.